
Edda Technology Inc Profile last edited on: 10/19/21
CAGE:
UEI:
Business Identifier: NO Business Identifier is currently available for this company. Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Multiple
Congr. District: 12
County: Mercer
Congr. District: 12
County: Mercer
Public Profile
EDDA Technology, Inc. is an innovative clinical computer solution provider that designs, patents, develops, and markets proprietary intelligent software systems for optimal clinical workflow. The company's product line, IQQA® (Intelligent/Interactive Qualitative and Quantitative Analysis), seamlessly integrates advanced diagnostic analysis technology into physicians' softcopy reading process for improved workflow and clinical decision making. It provides real-time interactive assistant tools to aid radiologists in extracting diagnostic information from large amount of diagnostic data. By bridging the gap between physicians' subjective interpretation based upon patient-specific knowledge and computer's object measurement from information fusion, IQQA® helps physicians increase their clinical performance and throughputs. EDDA's debut product, IQQA® -Chest, has received regulatory clearance from the US FDA and the Chinese SFDA (State Food and Drug Administration). It also carries the CE mark. EDDA's second product, IQQA® -Liver, has received regulatory clearance from the US FDA and the Chinese SFDA (State Food and Drug Administration). The company is headquartered in Princeton, New Jersey, with a subsidiary in Shanghai, China.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
25-49Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2004 | 1 | NIH | $147,000 | |
Project Title: Methods for Quality Assurance of Lesion/Cancer Marking |
Key People / Management
Jianzhong Qian -- President
Company News
There are no news available.